Itzhak Nir
Lynn Saavedra
A new program at the University of New Mexico Comprehensive Cancer Center aims to streamline cancer treatment for all New Mexicans, regardless of where they live in the state.
Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
